{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:04:02Z","timestamp":1766466242831,"version":"build-2065373602"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11605-020-04771-8","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T12:04:07Z","timestamp":1597665847000},"page":"303-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies"],"prefix":"10.1016","volume":"25","author":[{"given":"Mackenzie C.","family":"Morris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan M.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6442-1857","authenticated-orcid":false,"given":"Sameer H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-020-04771-8_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4613-1247-5_6","article-title":"Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology","volume":"82","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1007\/s11605-020-04771-8_bb0015","doi-asserted-by":"crossref","unstructured":"Jacquet, P and Sugarbaker, PH. Peritoneal-plasma barrier. Cancer Treat Res 1996;82(53-63.","DOI":"10.1007\/978-1-4613-1247-5_4"},{"issue":"2","key":"10.1007\/s11605-020-04771-8_bb0020","first-page":"253","article-title":"Hyperthermic peritoneal perfusion system in canines","volume":"40","author":"Spratt","year":"1980","journal-title":"Cancer Res"},{"key":"10.1007\/s11605-020-04771-8_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4613-1245-1_13","article-title":"Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy","volume":"81","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"5","key":"10.1007\/s11605-020-04771-8_bb0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/02656730701455318","article-title":"Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy","volume":"23","author":"Sugarbaker","year":"2007","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s002689900560","article-title":"Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features","volume":"23","author":"Portilla","year":"1999","journal-title":"World J Surg"},{"issue":"3","key":"10.1007\/s11605-020-04771-8_bb0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U","article-title":"Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis","volume":"14","author":"Sugarbaker","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"10.1007\/s11605-020-04771-8_bb0045","doi-asserted-by":"crossref","unstructured":"Jacquet, P and Sugarbaker, PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996;82(359-374.","DOI":"10.1007\/978-1-4613-1247-5_23"},{"issue":"3","key":"10.1007\/s11605-020-04771-8_bb0050","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjsurg.2019.09.017","article-title":"Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"219","author":"Beal","year":"2020","journal-title":"Am J Surg"},{"issue":"3","key":"10.1007\/s11605-020-04771-8_bb0055","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s11605-019-04441-4","article-title":"Peritoneal Metastases in Colorectal Cancer: Biology and Barriers","volume":"24","author":"Xue","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"10.1007\/s11605-020-04771-8_bb0060","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11605-014-2726-7","article-title":"The rise in appendiceal cancer incidence: 2000-2009","volume":"19","author":"Marmor","year":"2015","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"10.1007\/s11605-020-04771-8_bb0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/COC.0000000000000210","article-title":"Incidence and Survival of Appendiceal Mucinous Neoplasms: A SEER Analysis","volume":"40","author":"Shaib","year":"2017","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process","volume":"40","author":"Peritoneal Surface Oncology Group, I","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1007\/s11605-020-04771-8_bb0075","doi-asserted-by":"crossref","unstructured":"Ronnett, BM, Zahn, CM, Kurman, RJ, Kass, ME, Sugarbaker, PH, and Shmookler, BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \"pseudomyxoma peritonei\". Am J Surg Pathol 1995;19(12):1390-1408.","DOI":"10.1097\/00000478-199512000-00006"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R","article-title":"Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis","volume":"92","author":"Ronnett","year":"2001","journal-title":"Cancer"},{"issue":"9","key":"10.1007\/s11605-020-04771-8_bb0085","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1245\/s10434-010-0984-5","article-title":"A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin","volume":"17","author":"Bruin","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1007\/s11605-020-04771-8_bb0090","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1177\/000313481307901120","article-title":"Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival","volume":"79","author":"Shetty","year":"2013","journal-title":"Am Surg"},{"issue":"8","key":"10.1007\/s11605-020-04771-8_bb0095","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.humpath.2014.03.007","article-title":"Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin","volume":"45","author":"Sirintrapun","year":"2014","journal-title":"Hum Pathol"},{"year":"2017","key":"10.1007\/s11605-020-04771-8_bb0100"},{"issue":"8","key":"10.1007\/s11605-020-04771-8_bb0105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00384-014-1933-8","article-title":"Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin","volume":"29","author":"Jarvinen","year":"2014","journal-title":"Int J Colorectal Dis"},{"issue":"20","key":"10.1007\/s11605-020-04771-8_bb0110","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1007\/s11605-020-04771-8_bb0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13193-018-00870-w","article-title":"Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSO","volume":"10","author":"Sinukumar","year":"2019","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"10.1007\/s11605-020-04771-8_bb0120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.sla.0000133183.15705.71","article-title":"Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy","volume":"240","author":"Glehen","year":"2004","journal-title":"Ann Surg"},{"issue":"8","key":"10.1007\/s11605-020-04771-8_bb0125","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","article-title":"Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy","volume":"6","author":"Sugarbaker","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1007\/s11605-020-04771-8_bb0130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/ans.14985","article-title":"Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasms","volume":"89","author":"Narasimhan","year":"2019","journal-title":"ANZ J Surg"},{"issue":"7","key":"10.1007\/s11605-020-04771-8_bb0135","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/DCR.0000000000001076","article-title":"Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma","volume":"61","author":"Aziz","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1007\/s11605-020-04771-8_bb0140","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1245\/s10434-015-4446-y","article-title":"A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix","volume":"22","author":"Dineen","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1007\/s11605-020-04771-8_bb0145","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1245\/s10434-017-6275-7","article-title":"Prediction of Resectability in Pseudomyxoma Peritonei with a New CT Score","volume":"25","author":"Bouquot","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1245\/s10434-019-07626-y","article-title":"Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative","volume":"27","author":"Zaidi","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1007\/s11605-020-04771-8_bb0155","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1245\/s10434-017-5938-8","article-title":"Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection","volume":"24","author":"Grotz","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1007\/s11605-020-04771-8_bb0160","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1245\/s10434-017-6315-3","article-title":"PCI is Not Predictive of Survival After Complete CRS\/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries","volume":"25","author":"Votanopoulos","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1007\/s11605-020-04771-8_bb0165","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/SLA.0b013e318190eddc","article-title":"Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period","volume":"248","author":"Rosenberg","year":"2008","journal-title":"Ann Surg"},{"issue":"10","key":"10.1007\/s11605-020-04771-8_bb0170","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.3748\/wjg.v22.i10.2875","article-title":"Gastric cancer: Current status of lymph node dissection","volume":"22","author":"Degiuli","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1007\/s11605-020-04771-8_bb0175","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1245\/s10434-015-4415-5","article-title":"Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review","volume":"22","author":"Nash","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1245\/s10434-011-1903-0","article-title":"Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer","volume":"19","author":"Halabi","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-020-04771-8_bb0185","doi-asserted-by":"crossref","unstructured":"Gonzalez-Moreno, S and Sugarbaker, PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg 2004;91(3):304-311.","DOI":"10.1002\/bjs.4393"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10434-004-1161-5","article-title":"Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"12","author":"Gonzalez-Moreno","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11605-019-04336-4","article-title":"Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative","volume":"24","author":"Levinsky","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"13","key":"10.1007\/s11605-020-04771-8_bb0200","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1245\/s10434-014-3869-1","article-title":"Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"21","author":"Jimenez","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0205","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","article-title":"Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"245","author":"Smeenk","year":"2007","journal-title":"Ann Surg"},{"issue":"4","key":"10.1007\/s11605-020-04771-8_bb0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jso.20107","article-title":"Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix","volume":"87","author":"Carmignani","year":"2004","journal-title":"J Surg Oncol"},{"issue":"8","key":"10.1007\/s11605-020-04771-8_bb0215","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/codi.12924","article-title":"Elevated tumour markers are normalized in most patients with pseudomyxoma peritonei 7 days after complete tumour removal","volume":"17","author":"Di Fabio","year":"2015","journal-title":"Colorectal Dis"},{"issue":"10","key":"10.1007\/s11605-020-04771-8_bb0220","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/BF02574513","article-title":"Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"9","author":"van Ruth","year":"2002","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1007\/s11605-020-04771-8_bb0225","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1245\/s10434-012-2627-5","article-title":"Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin","volume":"20","author":"Wagner","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1007\/s11605-020-04771-8_bb0230","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/oxfordjournals.aje.a009093","article-title":"Analysis of current trends in United States mesothelioma incidence","volume":"145","author":"Price","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","article-title":"Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008","volume":"19","author":"Henley","year":"2013","journal-title":"Int J Occup Environ Health"},{"issue":"6","key":"10.1007\/s11605-020-04771-8_bb0240","first-page":"935","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1007\/s11605-020-04771-8_bb0245","first-page":"311","article-title":"Malignant peritoneal mesothelioma: review of 25 patients","volume":"75","author":"Brenner","year":"1981","journal-title":"Am J Gastroenterol"},{"key":"10.1007\/s11605-020-04771-8_bb0250","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM196503182721104","article-title":"Relation between Exposure to Asbestos and Mesothelioma","volume":"272","author":"Selikoff","year":"1965","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1007\/s11605-020-04771-8_bb0255","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review","volume":"18","author":"Boffetta","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1007\/s11605-020-04771-8_bb0260","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12967-015-0485-1","article-title":"BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma","volume":"13","author":"Alakus","year":"2015","journal-title":"J Transl Med"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/030089160509100101","article-title":"Malignant peritoneal mesothelioma","volume":"91","author":"de Pangher Manzini","year":"2005","journal-title":"Tumori"},{"issue":"2","key":"10.1007\/s11605-020-04771-8_bb0270","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdp307","article-title":"Malignant peritoneal mesothelioma: a multicenter study on 81 cases","volume":"21","author":"Manzini Vde","year":"2010","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1007\/s11605-020-04771-8_bb0275","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PAT.0b013e3283631cce","article-title":"Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy","volume":"45","author":"Lee","year":"2013","journal-title":"Pathology"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1007\/s11605-020-04771-8_bb0285","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cncr.25640","article-title":"A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*","volume":"117","author":"Peritoneal Surface Oncology, G","year":"2011","journal-title":"Cancer"},{"issue":"11","key":"10.1007\/s11605-020-04771-8_bb0290","doi-asserted-by":"crossref","first-page":"236","DOI":"10.21037\/atm.2017.03.96","article-title":"Malignant peritoneal mesothelioma: a review","volume":"5","author":"Kim","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1007\/s11605-020-04771-8_bb0295","doi-asserted-by":"crossref","unstructured":"Kusamura, S, Kepenekian, V, Villeneuve, L, Lurvink, RJ, Govaerts, K, De Hingh, I, Moran, BJ, Van der Speeten, K, Deraco, M, Glehen, O, and Psogi. Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 2020;","DOI":"10.1016\/j.ejso.2020.02.011"},{"issue":"6","key":"10.1007\/s11605-020-04771-8_bb0300","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1200\/JCO.1983.1.6.386","article-title":"Peritoneal mesothelioma: natural history and response to chemotherapy","volume":"1","author":"Antman","year":"1983","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","article-title":"Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program","volume":"7","author":"Janne","year":"2005","journal-title":"Clin Lung Cancer"},{"issue":"21","key":"10.1007\/s11605-020-04771-8_bb0310","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","article-title":"Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial","volume":"26","author":"Simon","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10026","key":"10.1007\/s11605-020-04771-8_bb0315","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"French Cooperative Thoracic, I","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1007\/s11605-020-04771-8_bb0320","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1245\/s10434-012-2845-x","article-title":"The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"20","author":"Deraco","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1007\/s11605-020-04771-8_bb0325","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1245\/s10434-010-1080-6","article-title":"Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin","volume":"17","author":"Blackham","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1007\/s11605-020-04771-8_bb0330","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"issue":"36","key":"10.1007\/s11605-020-04771-8_bb0335","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1007\/s11605-020-04771-8_bb0340","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1245\/s10434-018-6499-1","article-title":"Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival","volume":"25","author":"Verma","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-020-04771-8_bb0345","doi-asserted-by":"crossref","unstructured":"Leinwand, JC, Taub, RN, Chabot, JA, and Kluger, MD. Two-Stage Cytoreductive Surgery and Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma: Predictors of Overall Survival in an Intention-to-Treat Series. Ann Surg Oncol 2019;","DOI":"10.1245\/s10434-019-08139-4"},{"issue":"15","key":"10.1007\/s11605-020-04771-8_bb0350","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","article-title":"Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"49","author":"Baratti","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1007\/s11605-020-04771-8_bb0355","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2016\/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019."},{"issue":"3","key":"10.1007\/s11605-020-04771-8_bb0360","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1007\/s11605-020-04771-8_bb0365","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00268-002-6279-7","article-title":"Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer","volume":"27","author":"Wu","year":"2003","journal-title":"World J Surg"},{"issue":"10","key":"10.1007\/s11605-020-04771-8_bb0370","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.ejso.2014.01.006","article-title":"Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: an updated meta-analysis of randomized controlled trials","volume":"40","author":"Xiong","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1007\/s11605-020-04771-8_bb0375","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U","article-title":"Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C","volume":"61","author":"Koga","year":"1988","journal-title":"Cancer"},{"key":"10.1007\/s11605-020-04771-8_bb0380","doi-asserted-by":"crossref","unstructured":"Fujimura, T, Yonemura, Y, Muraoka, K, Takamura, H, Hirono, Y, Sahara, H, Ninomiya, I, Matsumoto, H, Tsugawa, K, Nishimura, G, and et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg 1994;18(1):150-155.","DOI":"10.1007\/BF00348209"},{"issue":"3","key":"10.1007\/s11605-020-04771-8_bb0385","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<529::AID-CNCR3>3.0.CO;2-9","article-title":"Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma","volume":"85","author":"Fujimoto","year":"1999","journal-title":"Cancer"},{"issue":"42","key":"10.1007\/s11605-020-04771-8_bb0390","first-page":"1776","article-title":"Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study","volume":"48","author":"Yonemura","year":"2001","journal-title":"Hepatogastroenterology"},{"issue":"8","key":"10.1007\/s11605-020-04771-8_bb0395","first-page":"581","article-title":"Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion","volume":"161","author":"Ikeguchi","year":"1995","journal-title":"Eur J Surg"},{"issue":"8","key":"10.1007\/s11605-020-04771-8_bb0400","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/1097-0142(19940415)73:8<2048::AID-CNCR2820730806>3.0.CO;2-Q","article-title":"Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study","volume":"73","author":"Hamazoe","year":"1994","journal-title":"Cancer"},{"key":"10.1007\/s11605-020-04771-8_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","article-title":"The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer","volume":"79","author":"Desiderio","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1007\/s11605-020-04771-8_bb0410","doi-asserted-by":"crossref","unstructured":"Fujimoto, S, Shrestha, RD, Kokubun, M, Ohta, M, Takahashi, M, Kobayashi, K, Kiuchi, S, Okui, K, Miyoshi, T, Arimizu, N, and et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208(1):36-41.","DOI":"10.1097\/00000658-198807000-00005"},{"key":"10.1007\/s11605-020-04771-8_bb0415","doi-asserted-by":"crossref","unstructured":"Fujimoto, S, Shrestha, RD, Kokubun, M, Kobayashi, K, Kiuchi, S, Konno, C, Ohta, M, Takahashi, M, Kitsukawa, Y, Mizutani, M, and et al. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg 1990;212(5):592-596.","DOI":"10.1097\/00000658-199011000-00005"},{"issue":"4","key":"10.1007\/s11605-020-04771-8_bb0420","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0039-6060(96)80145-0","article-title":"Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination","volume":"119","author":"Yonemura","year":"1996","journal-title":"Surgery"},{"issue":"2B","key":"10.1007\/s11605-020-04771-8_bb0425","first-page":"1375","article-title":"Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis","volume":"19","author":"Sayag-Beaujard","year":"1999","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1007\/s11605-020-04771-8_bb0430","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Association Francaise de, C","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-020-04771-8_bb0435","doi-asserted-by":"crossref","unstructured":"Kimbrough, CW, Beal, E, Abdel-Misih, S, Pawlik, TM, and Cloyd, JM. Survival Outcomes Among Patients With Gastric Adenocarcinoma Who Received Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery. JAMA Surg 2019;","DOI":"10.1001\/jamasurg.2019.1698"},{"issue":"6","key":"10.1007\/s11605-020-04771-8_bb0440","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0445","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","article-title":"Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials","volume":"40","author":"Coccolini","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1007\/s11605-020-04771-8_bb0450","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1245\/s10434-017-6047-4","article-title":"Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma","volume":"24","author":"Badgwell","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1007\/s11605-020-04771-8_bb0455","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1245\/s10434-009-0774-0","article-title":"Malignant ascites symptom cluster in patients referred for paracentesis","volume":"17","author":"Husain","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1007\/s11605-020-04771-8_bb0460","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","article-title":"Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures","volume":"4","author":"Sangisetty","year":"2012","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0465","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/ejso.2000.1033","article-title":"Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis","volume":"27","author":"McQuellon","year":"2001","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1007\/s11605-020-04771-8_bb0470","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-012-2360-0","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature","volume":"19","author":"Facchiano","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1007\/s11605-020-04771-8_bb0475","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1007\/s11605-020-04771-8_bb0480","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol Med"},{"issue":"22","key":"10.1007\/s11605-020-04771-8_bb0485","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.291.22.2705","article-title":"Frequency of symptoms of ovarian cancer in women presenting to primary care clinics","volume":"291","author":"Goff","year":"2004","journal-title":"JAMA"},{"issue":"28","key":"10.1007\/s11605-020-04771-8_bb0490","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","article-title":"Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Wright","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-020-04771-8_bb0495","first-page":"CD005340","article-title":"Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer","volume":"1","author":"Jaaback","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1007\/s11605-020-04771-8_bb0500","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients","volume":"39","author":"Group, F","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1007\/s11605-020-04771-8_bb0505","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/IGC.0b013e31824d836c","article-title":"Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer","volume":"22","author":"Ansaloni","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1007\/s11605-020-04771-8_bb0510","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1007\/s11605-020-04771-8_bb0515","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ejso.2015.08.172","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: A systematic review and meta-analysis","volume":"41","author":"Huo","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1007\/s11605-020-04771-8_bb0520","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1007\/s11605-020-04771-8_bb0525","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2012.09.020","article-title":"Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up","volume":"127","author":"Fagotti","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1007\/s11605-020-04771-8_bb0530","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1245\/s10434-015-5050-x","article-title":"Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)","volume":"23","author":"Petrillo","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1007\/s11605-020-04771-8_bb0535","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-020-04771-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11605-020-04771-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23007710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23007710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-020-04771-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:01:27Z","timestamp":1761076887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23007710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1091255X23007710"],"URL":"https:\/\/doi.org\/10.1007\/s11605-020-04771-8","relation":{},"ISSN":["1091-255X"],"issn-type":[{"type":"print","value":"1091-255X"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-020-04771-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}